4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-010224
Senior VP, Chief Pharma Dev. sold 1,227 shares at an average $341.07 ($418,488)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2025-02-28 | Sale | −1,052 | $340.99 | $358,717 | 3,903 | D |
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2025-02-28 | Sale | −175 | $341.55 | $59,771 | 3,728 | D |
| Open-market sales · 1,227 sh · avg $341.07 · $418,488 | |||||||
Loading xslF345X05/wk-form4_1741141462.xml…